First reported clinical use of CRISPR-edited cells in a human cancer patient
Dated 28 October 2016: First reported clinical use of CRISPR-edited cells in a human cancer patient. In the causal graph this event strengthens the driver Biotechnology Innovation.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
No public contributors are listed for this fact.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactFirst reported clinical use of CRISPR-edited cells in a human cancer patient
- strengthensDriverBiotechnology Innovation
provisional weight · verified
Causal path
How this event connects to drivers and indicators in the graph.
- FactFirst reported clinical use of CRISPR-edited cells in a human cancer patient
- strengthensDriverBiotechnology Innovation
Cite this page
Factrail. (2026). First reported clinical use of CRISPR-edited cells in a human cancer patient. Factrail. https://factrail.ai/facts/crispr-first-human-clinical-injection-china-2016
https://factrail.ai/facts/crispr-first-human-clinical-injection-china-2016
Accessed 15 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.